SpyBiotech
Oxford
About SpyBiotech
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.The company's biotechnology platform develops bonding vaccines which are made from the proprietary protein superglue which is used to bond antigens to viruses and other particles to make vaccines, enabling medical institutions and research centers with a new and modified technology to develop vaccines which give better results in lesser time.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $41.6M
- Funding stage: Early Stage Venture
- Last round: Grant (Mar 2023)
- Website: spybiotech.com
- Phone: +4401865582088
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/spybiotech-63735 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.